Units Available

View the list of units available to rent or buy at Queens Meadow, HartlepoolTo Offices

Unit Available

Expansion for Hart Biologicals Ltd.... tell me more

News Archive

Hart Biologicals Wins Prestigious Biomedical Sector Awards

02 June 2014


Hart Biologicals

On 24 April 2014, the best of the North of England’s biomedical companies were honoured at the 2014 Biomedical Awards, hosted by Bionow at the BALTIC Centre for Contemporary Art, on Gateshead Quays.  Rivergreen tenant Hart Biologicals Ltd. won two of the five awards up for grabs.  Hart is engaged in the research, development, manufacture and marketing of ‘in-vitro’ diagnostic products, which are used in the detection, prevention and monitoring of a number of medical conditions relating to haemostasis and platelet function.

In 2013, the company achieved over £850,000 of export sales in Germany alone, as well as adding contracts in both Europe and the USA to its manufacturing base.   These achievements were recognised by the Export Award sponsored by CBSL.

The ceremony also saw Hart Biologicals’ Keighley Campbell named Promising Technologist of the Year. Having joined Hart in 2010 as a Research & Development Scientist, she was successful in the development of a range of coagulation reagents for use in hospital pathology laboratory testing products - these are now on sale around the world.  Keighley was promoted to Research & Development Manager in 2012 and is working on product design and development that covers Hart Biologicals’ own-label products and development activities for contract manufacturing opportunities.

The North of England is one of the UK and Europe's largest biomedical regions; 20% of the UK’s biomedical companies, employment and turnover are in the North.  Comprising of 925 life science and healthcare companies, the sector generates a turnover of £10.9bn and employs over 38,000 people. The area is home to the N8 Research Partnership, and boasts world-leading resources in terms of investment, scientific expertise, academic research, science graduates, NHS hospitals and state of the art manufacturing facilities.